Skip to main content
Premium Trial:

Request an Annual Quote

Following Reverse Merger with Xtrana, Alpha Innotech Trades on OTCBB

NEW YORK, Oct. 10 (GenomeWeb News) - Alpha Innotech and Xtrana have closed a reverse merger, the companies said last week.


The merged company changed its name to Alpha Innotech and began trading on the NASD over-the-counter bulletin board under the new name last week, following a one-for-ten reverse stock split.


Alpha Innotech shareholders and Xtrana stockholders approved the merger earlier this month. All outstanding capital stock of Alpha Innotech, which was privately held prior to the merger, was converted into the right to receive shares of Xtrana common stock.


Alpha Innotech, based in San Leandro, Calif., provides digital imaging and detection system for life science research. The company combines instruments, reagents, and bioinformatics software to offer integrated technology platforms for electrophoresis, functional genomics, proteomics, and cell analysis. The company had $10.5 million in revenues last year.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.